Second round of COVID booster sought as concerns of efficacy after six months for immune-compromise
As new-case COVID numbers maintain a downward trend, both drug manufacturers Pfizer and Moderna are asking the Federal Drug Administration and Centers for Disease Control for a recommendation for yet another booster in the vaccination protocol.
